Previous Chapter: 1 Introduction
Suggested Citation: "2 Overview of the Glutamatergic System." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 5
Suggested Citation: "2 Overview of the Glutamatergic System." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 6
Suggested Citation: "2 Overview of the Glutamatergic System." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 7
Suggested Citation: "2 Overview of the Glutamatergic System." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 8
Suggested Citation: "2 Overview of the Glutamatergic System." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 9
Suggested Citation: "2 Overview of the Glutamatergic System." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 10
Next Chapter: 3 Glutamate Biomarkers
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.